NCT03799705View on ClinicalTrials.gov

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Vacterl AssociationCongenital Malformation
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03799705 - Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway | Biotech Hunter | Biotech Hunter